[Drug treatment for hypertrophic cardiomyopathy] Presse médicale (Paris, France : 1983) [Presse Med] Journal article

Title	[Drug treatment for hypertrophic cardiomyopathy]
Author(s)	Gibelin P
Institution	Service de cardiologie, Hôpital Pasteur, CHU Nice, Nice Cedex 1, France. gibelin.p@chu-nice.fr
Source	Presse Med 2009 Jun; 38(6):1001-4.
MeSH	Adrenergic beta-Antagonists Anti-Arrhythmia Agents Anticoagulants Atrial Fibrillation Cardiomyopathy, Hypertrophic Chest Pain Death, Sudden, Cardiac Disopyramide Diuretics Drug Monitoring Dyspnea Embolism Endocarditis Heart Failure, Systolic Humans Myocardial Ischemia Patient Selection Vasodilator Agents Verapamil
Abstract	Drug treatment of hypertrophic cardiomyopathy is the first-line treatment, at the onset of clinical signs and symptoms. Beta-blockers are proposed for symptomatic patients with no gradient or with a gradient that appears only on exertion. Verapamil is the standard second-line drug,when the beta-blockers are insufficient or ineffective but must be avoided when there is blockage at rest with severe symptoms. Disopyramide is indicated for patients with obstruction who do not respond to beta blockers and/or verapamil. Treatment with anticoagulants is widely prescribed because this disease is highly emboligenic.
Language	fre
Pub Type(s)	English Abstract Journal Article
PubMed ID	19446431

Advertise on this site.